• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

Stereotaxis submits robotically navigated ablation catheter for CE mark

July 11, 2022 By Sean Whooley

Stereotaxis Magic ablation catheterStereotaxis (NYSE:STXS) announced today that it submitted its MAGiC catheter for CE mark approval in Europe.

The St. Louis-based company designed MAGiC as a robotically navigated, magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures.

Used in conjunction with Stereotaxis’ robotic systems, the catheter provides precision, stability and flexibility when diagnosing and treating cardiac arrhythmias, according to a news release. The catheter was developed in collaboration with Osypka, a German medical device company that pioneered the development of radiofrequency ablation for cardiac arrhythmias.

MAGiC was designed to incorporate a wide array of features to enhance patient safety and efficacy, procedural efficiency, and the physician experience.

“The electrophysiology community has long awaited innovation in robotic catheter technology, and we are very excited by the near-term availability of the MAGiC catheter,” Dr. Sabine Ernst, Cardiologist at Royal Brompton & Harefield Hospitals and Professor of Practice in Cardiology at Imperial College London, said in the release. “I believe MAGiC will be a significant leap forward in clinical care for my patients and improved robotic performance.”

Stereotaxis said MAGiC represents the first in a series of interventional devices being developed by the company, serving as a platform for future innovations. The company seeks to make the catheter commercially available for robotic electrophysiology practices in Europe after the receipt of CE mark as early as the end of the year. Separately, the company is working on the submission of an application to the FDA to begin a prospective investigational device exemption trial in the U.S.

“We are very pleased to reach this important milestone. This is a seminal event for Stereotaxis as a company and for the physician community that is pioneering the frontiers of robotics in electrophysiology,” Stereotaxis Chair and CEO David Fischel said. “Our attention is focused on preparing for commercial launch of the catheter once we receive regulatory clearance. We look forward to the positive impact MAGiC can have on patients, physicians, providers and medical progress.”

Filed Under: Catheters Tagged With: CE Mark, Stereotaxis

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS